Detalles de la búsqueda
1.
Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 study.
Allergy;
79(4): 924-936, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37984453
2.
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.
J Am Acad Dermatol;
90(5): 986-993, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38253129
3.
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
Br J Dermatol;
189(4): 392-399, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37279795
4.
DMT310, a novel once-weekly topical treatment for patients with moderate-to-severe acne vulgaris: Results of a phase 2b randomized, double-blind, placebo-controlled trial.
J Am Acad Dermatol;
89(5): 945-951, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37295506
5.
Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: A phase II, randomized, controlled, double-blinded trial.
J Am Acad Dermatol;
82(6): 1321-1327, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32068049
6.
Assessing Patients' Satisfaction With Hydrogen Peroxide Topical Solution, 40% for Treatment of Raised Seborrheic Keratoses.
J Drugs Dermatol;
19(12): 1184-1191, 2020 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33346520
7.
Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results.
J Drugs Dermatol;
19(11): 1093-1100, 2020 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33196758
8.
Patient-Reported Outcomes in Acne Patients With Skin of Color Using Adapalene 0.3%-Benzoyl Peroxide 2.5%: A Prospective Real-World Study
J Drugs Dermatol;
18(5): 514, 2019 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31251543
9.
WITHDRAWN: Efficacy and safety of topical oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 2 phase 3, 29-day, randomized, controlled REVEAL trials.
J Am Acad Dermatol;
2018 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29409915
10.
A-101, a Proprietary Topical Formulation of High-Concentration Hydrogen Peroxide Solution: A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Dose-Response Profile in Subjects With Seborrheic Keratosis of the Face.
Dermatol Surg;
44(3): 330-340, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28902028
11.
Clinical Pharmacokinetics of Oxymetazoline Cream Following Topical Facial Administration for the Treatment of Erythema Associated With Rosacea.
J Drugs Dermatol;
17(2): 213-220, 2018 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29462230
12.
Phase 2 Randomized, Dose-Ranging Study of Oxymetazoline Cream for Treatment of Persistent Facial Erythema Associated With Rosacea.
J Drugs Dermatol;
17(3): 308-316, 2018 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29537449
13.
Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.
J Drugs Dermatol;
17(1): 97-105, 2018 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29320594
14.
Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials
J Drugs Dermatol;
17(11): 1201-1208, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30500142
15.
Pharmacokinetics, Safety, and Tolerability of a Single 5-Day Treatment of Tirbanibulin Ointment 1% in 100 cm2 : A Phase 1 Maximal-Use Trial in Patients with Actinic Keratosis.
Clin Pharmacol Drug Dev;
13(2): 208-218, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38185925
16.
Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.
Sci Adv;
10(18): eadk4946, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38691597
17.
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
JAMA Dermatol;
159(6): 613-620, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37133856
18.
Clinical Pharmacokinetics and Safety of a 10% Aminolevulinic Acid Hydrochloride Nanoemulsion Gel (BF-200 ALA) in Photodynamic Therapy of Patients Extensively Affected With Actinic Keratosis: Results of 2 Maximal Usage Pharmacokinetic Trials.
Clin Pharmacol Drug Dev;
11(4): 535-550, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34633154
19.
Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics.
Am J Clin Dermatol;
23(1): 83-91, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34713415
20.
Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial.
Clin Cosmet Investig Dermatol;
14: 1507-1517, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34703265